Quote:ht tps: // ww w. federal register. gov/documents/2023/12/21/2023-27935/institutional-review-board-waiver-or-alteration-of-informed-consent-for-minimal-risk-clinical

(fair use applies) DELIBERATELY BROKEN LINK

EXCERPT (I only posted the summary - the entire piece is at the link)


~~~~~~~~~~~~~~~~~~~~~~~~~~~~~


This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.


Publication Date:

12/21/2023


AGENCY:

[b]Food and Drug Administration, HHS.[/b]

ACTION:

[b]Final rule.[/b]

SUMMARY:

The Food and Drug Administration (FDA, the Agency, or we) is issuing a final rule to amend its regulations to implement a provision of the 21st Century Cures Act (Cures Act).[b] This final rule allows an exception from the requirement to obtain informed consent when a clinical investigation poses no more than minimal risk to the human subject and includes appropriate safeguards to protect the rights, safety, and welfare of human subjects. The final rule permits an institutional review board (IRB) to waive or alter certain informed consent elements or to waive the requirement to obtain informed consent, under limited conditions, for certain FDA-regulated minimal risk clinical investigations.[/b]

DATES:

[b]This rule is effective January 22, 2024.[/b]